{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:50:41Z","timestamp":1782190241631,"version":"3.54.5"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004914","name":"Ferring Pharmaceuticals","doi-asserted-by":"publisher","award":["000001"],"award-info":[{"award-number":["000001"]}],"id":[{"id":"10.13039\/501100004914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004914","name":"Ferring Pharmaceuticals","doi-asserted-by":"publisher","award":["RITA-2"],"award-info":[{"award-number":["RITA-2"]}],"id":[{"id":"10.13039\/501100004914","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.fertnstert.2025.07.032","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T23:08:03Z","timestamp":1753398483000},"page":"54-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ovarian stimulation with follitropin delta is safe and effective: results from the RITA randomized, double-blind, placebo-controlled trials"],"prefix":"10.1016","volume":"125","author":[{"given":"Michael D.","family":"Scheiber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Doody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Heiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2025.07.032_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-0035-1546424","article-title":"Best practices for controlled ovarian stimulation in in vitro fertilization","volume":"33","author":"Jungheim","year":"2015","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2025.07.032_bib2","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/jcph.328","article-title":"Different pharmacokinetic and pharmacodynamic properties of recombinant follicle-stimulating hormone (rFSH) derived from a human cell line compared with rFSH from a non-human cell line","volume":"54","author":"Olsson","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.fertnstert.2025.07.032_bib3","series-title":"Anti-M\u00fcllerian hormone","first-page":"83","article-title":"Using AMH for determining a stratified gonadotropin dosing regimen for IVF\/ICSI and optimizing outcomes","author":"Arce","year":"2016"},{"key":"10.1016\/j.fertnstert.2025.07.032_bib4","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.fertnstert.2014.08.013","article-title":"Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antim\u00fcllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization\/intracytoplasmic sperm injection","volume":"102","author":"Arce","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.07.032_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s40268-016-0129-9","article-title":"Population pharmacokinetic modelling of FE 999049, a recombinant human follicle-stimulating hormone, in healthy women after single ascending doses","volume":"16","author":"Rose","year":"2016","journal-title":"Drugs R D"},{"key":"10.1016\/j.fertnstert.2025.07.032_bib6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.fertnstert.2016.10.033","article-title":"Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial","volume":"107","author":"Nyboe Andersen","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.07.032_bib7","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1093\/humrep\/deab155","article-title":"A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF\/ICSI patients","volume":"36","author":"Qiao","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2025.07.032_bib8","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.rbmo.2021.01.023","article-title":"Individualized follitropin delta dosing reduces OHSS risk in Japanese IVF\/ICSI patients: a randomized controlled trial","volume":"42","author":"Ishihara","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2025.07.032_bib9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.fertnstert.2024.05.143","article-title":"Individualized dosing of follitropin delta affects live birth and safety in in vitro fertilization treatment: an individual participant data meta-analysis of randomized controlled trials","volume":"122","author":"Nelson","year":"2024","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.07.032_bib10","series-title":"Towards reproductive certainty: fertility and genetics beyond. Carnforth","first-page":"378","article-title":"In-vitro culture of human blastocysts","author":"Garder","year":"1999"},{"key":"10.1016\/j.fertnstert.2025.07.032_bib11","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","article-title":"Ovarian hyperstimulation syndrome: an update review","volume":"44","author":"Golan","year":"1989","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.fertnstert.2025.07.032_bib12","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.fertnstert.2012.02.038","article-title":"A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormone","volume":"97","author":"Boostanfar","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.07.032_bib13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.fertnstert.2016.03.041","article-title":"Efficacy and safety of frozen-thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial","volume":"106","author":"Boostanfar","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.07.032_bib15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.fertnstert.2018.04.039","article-title":"Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization\/intracytoplasmic sperm injection: a multicenter multinational analysis including \u223c15,000 women","volume":"110","author":"Polyzos","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.07.032_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2024.104451","article-title":"Oocyte yield and live birth rate after follitropin delta dosing and fresh embryo transfer: an individual patient data meta-analysis","volume":"50","author":"Lobo","year":"2025","journal-title":"Reprod Biomed Online"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028225006053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028225006053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:21:39Z","timestamp":1777393299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028225006053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0015028225006053"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2025.07.032","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian stimulation with follitropin delta is safe and effective: results from the RITA randomized, double-blind, placebo-controlled trials","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2025.07.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92025 The Authors. Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}